checkAd

     309  0 Kommentare Coloplast A/S - Announcement no. 08/2023 - Coloplast announces registration of share capital increase of 12.2 new B shares completed - Seite 2



     

    For further information, please contact

    Investors and analysts
    Anders Lonning-Skovgaard
    Executive Vice President, CFO
    Tel. +45 4911 1111

    Aleksandra Dimovska
    Senior Director, Investor Relations
    Tel. +45 4911 1800 / +45 4911 2458
    Email: dkadim@coloplast.com

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Coloplast Group!
    Short
    947,03€
    Basispreis
    1,50
    Ask
    × 10,04
    Hebel
    Long
    790,57€
    Basispreis
    0,74
    Ask
    × 9,53
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Kristine Husted Munk
    Senior Manager, Investor Relations
    Tel. +45 4911 1800 / +45 4911 3266
    Email: dkkhu@coloplast.com

    Press and media
    Peter Mønster
    Sr. Media Relations Manager
    Tel. +45 4911 2623
    Email: dkpete@coloplast.com

    Address
    Coloplast A/S
    Holtedam 1
    DK-3050 Humlebaek
    Denmark
    Company reg. (CVR) no. 69749917

    Website
    www.coloplast.com


    This announcement is available in an English and Danish-language version. In case of discrepancies, the English-language version shall prevail.

    Important information

    This company announcement contains forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties, in particular this announcement should not be construed as a confirmation that either the Offering will complete, nor of the deal size or the price. Therefore, actual future results and trends may differ materially from what is forecast in this report due to a variety of factors.

    This announcement is intended for the sole purpose of providing information. Persons needing advice should consult an independent financial adviser. This announcement does not constitute an investment recommendation.

    This announcement is not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States (including its territories and possessions, any state of the United States and the District of Columbia, the “United States”), Canada, Japan, South Africa, Hong Kong or Australia, except as permitted by applicable law, or any other jurisdiction in which such publication or distribution is unlawful.

    This announcement does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States, Canada, Japan, South Africa, Hong Kong, Australia or any other jurisdiction in which such offers or sales are unlawful (the “Excluded Territories”). Any failure to comply with this may constitute a violation of US, Canadian, Japanese, South African, Hong Kong or Australian securities laws or the securities laws of other jurisdiction as the case may be.

    Seite 2 von 5


    Diskutieren Sie über die enthaltenen Werte


    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Coloplast A/S - Announcement no. 08/2023 - Coloplast announces registration of share capital increase of 12.2 new B shares completed - Seite 2 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY OTHER …